ライフサイエンスコーパス: vas deferens

1 s tubule and collected by cannulation of the vas deferens.

2 s the lungs, pancreas, liver, intestine, and vas deferens.

3 ion in precapillary arterioles in ureter and vas deferens.

4 old greater in femoral artery as compared to vas deferens.

5 cellular CPI-17 concentration of the phasic vas deferens.

6 fluorescence in the tunica muscularis of the vas deferens.

7 y due to congenital bilateral absence of the vas deferens.

8 d predominantly to the cell periphery in the vas deferens.

9 c nerve terminals in the guinea-pig isolated vas deferens.

10 prostate, coagulating gland, epididymis, and vas deferens.

11 m in an immotile state in the epididymis and vas deferens (2,4-6).

12 infertility due to congenital absence of the vas deferens, 9 patients with nonclassic CF, and 27 unaf

13 intestines, lungs, pancreas, sweat ducts and vas deferens, among others.

14 As a result, the epididymis, vas deferens and efferent ductules were largely absent i

15 -smooth muscle preparation of the guinea-pig vas deferens and from isolated bovine adrenal chromaffin

16 he compounds described in the isolated mouse vas deferens and guinea pig ileum bioassays revealed tha

17 Evaluation of the ligands in the mouse vas deferens and guinea pig ileum preparations revealed

18 tional assays (electrically stimulated mouse vas deferens and guinea pig ileum).

19 determined from functional assays in rabbit vas deferens and inhibition constant (Ki) of 0.02 nM mea

20 ation of Wolffian ducts into the epididymis, vas deferens and seminal vesicle.

21 in normal P2X1 receptor functionality in the vas deferens and that its absence leads to impaired peri

22 cer Fluorogold into the junction between the vas deferens and the cauda labeled a population of neuro

23 In the vas deferens and the ileal submucosa, P2X1 immunoreactiv

24 al tract, including the seminal vesicle, the vas deferens and the prostate.

25 bnormal escape reflex, mispositioning of the vas deferens and uterus, and mitotic chromosome loss and

26 ctivity toward delta-opioid receptors (mouse vas deferens) and produced analgesia in mice in a naloxo

27 enotype, congenital bilateral absence of the vas deferens, and determined whether mutant CFTR could r

28 specific structures such as the epididymis, vas deferens, and seminal vesicle from a straight Wolffi

29 w that similar cells are also present in the vas deferens, and that a bafilomycin-sensitive proton fl

30 of principal cells of the epididymis and the vas deferens, and that both NHERF1 and CFTR co-immunopre

31 uterus anteriorized towards oviduct and the vas deferens anteriorized towards epididymis.

32 Native alpha1A-ARs from rat tail artery and vas deferens are also desensitized by OXY, but not by NE

33 ro (guinea pig ileum assay) and delta (mouse vas deferens assay) opioid receptors, respectively.

34 MH side chain exchange was seen in the mouse vas deferens assay.

35 t Phe3 was required for bioactivity in mouse vas deferens but not for interaction with delta opioid r

36 Wolffian duct and formed the epididymis and vas deferens, but failed to elaborate the efferent ductu

37 ents in single cells from the Syrian hamster vas deferens cell line DDT1MF-2 were investigated using

38 ere detected in epithelia of the epididymis, vas deferens, coagulating gland, preputial gland and sal

39 ]Norepinephrine release studies performed in vas deferens confirmed these findings.

40 Clear cells of the epididymis and vas deferens contain abundant V-ATPase in their apical p

41 The maximal inhibition of vas deferens contraction by the alpha2 agonist in alpha2

42 havior and sperm counts, but abnormal distal vas deferens convolution resulting in complete and incom

43 60 s with electrical field stimulation (EFS; vas deferens), dimethylphenylpiperazinium (chromaffin ce

44 meconium ileus (MI); pancreatic, liver, and vas deferens disease; and a predisposition to lung infec

45 In vitro, Entpd1(-/-) vas deferens displayed an exacerbated contraction to ATP

46 tically mediated sperm transport through the vas deferens during the emission phase of ejaculation.

47 +/- 0.4 million for Entpd1(+/+)) pointed to vas deferens dysfunction.

48 ; obstructing cysts of the seminal vesicles, vas deferens, ejaculatory ducts, or prostate in 26 (9.4%

49 erm effects of the polypropylene mesh on the vas deferens, especially with regard to fertility.

50 actile response to electrical stimulation in vas deferens from alpha2B-AR knockout, alpha2C-AR knocko

51 NCTs) in smooth muscle of the mouse isolated vas deferens has been used to detect the packeted releas

52 ganglionic sympathetic axon bundles in mouse vas deferens have been characterized using confocal micr

53 (15.6%) patients; unilateral absence of the vas deferens in 31 (11.2%) patients; obstructing cysts o

54 included congenital bilateral absence of the vas deferens in 94 (34.1%) patients; bilateral occlusion

55 structures (e.g., uterus in hermaphrodites, vas deferens in males).

56 well as congenital bilateral absence of the vas deferens in males.

57 riole as the sperm transits to the cauda and vas deferens in preparation for its climactic release.

58 t the CB1 and CB2 receptors and in the mouse vas deferens in vitro assay and the mouse tetrad in vivo

59 y cirrhosis), sweat glands (heat shock), and vas deferens (infertility).

60 Up to 80% of the net proton secretion in the vas deferens is inhibited by bafilomycin, consistent wit

61 focal biliary cirrhosis, micro-gallbladder, vas deferens loss, airway disease, and meconium ileus.

62 was devoid of agonist activity in the mouse vas deferens (MVD) and guinea pig ileum (GPI) preparatio

63 st functional activity in the mouse isolated vas deferens (MVD) and guinea pig isolated ileum (GPI) a

64 vity in the guinea pig ileum (GPI) and mouse vas deferens (MVD) functional bioassays were determined

65 itro on the guinea pig ileum (GPI) and mouse vas deferens (MVD) preparations.

66 dies in the guinea pig ileum (GPI) and mouse vas deferens (MVD) preparations.

67 ssays using guinea pig ileum (GPI) and mouse vas deferens (MVD) smooth muscle preparations.

68 of the guinea pig ileum (GPI) and the mouse vas deferens (MVD) with EC50 values of 1.82 +/- 0.16 and

69 of neurogenic contractions in the guinea pig vas deferens (n = 4-5).

70 mooth muscle was investigated in bladder and vas deferens of mice carrying a targeted mutation in bot

71 om postganglionic sympathetic neurons in the vas deferens of mice injected with IgG from LEMS patient

72 of the spicule-associated muscles pinch the vas deferens opening, thus blocking sperm release.

73 y due to congenital bilateral absence of the vas deferens or nonclassic cystic fibrosis.

74 d non-selective cation channels from the rat vas deferens (P2X1 receptors) were stably expressed in H

75 loned; of these, one was cloned from the rat vas deferens (P2X1) and another from pheochromocytoma (P

76 w of purines and noradrenaline (NA) from the vas deferens preparation differed from the pattern of ov

77 ow of NA and the purines from the guniea-pig vas deferens preparation was examined after treatment wi

78 lpha2-AR function was tested in two isolated vas deferens preparations.

79 cal-uterine junction, and the development of vas deferens-proctodeal connection in the male.

80 or-induced gene (FR-1) (80% identity), mouse vas deferens protein (MVDP) (76%), and human aldose redu

81 rly evident within sympathetic fibers of the vas deferens, reflecting a high degree of spatial organi

82 ympathetic nerves innervating the guinea-pig vas deferens releases not only neuronal ATP, but also so

83 Cultures from aorta, vas deferens, seminal vesicle, and kidney tissue were ch

84 (34.1%) patients; bilateral occlusion of the vas deferens, seminal vesicles, and ejaculatory ducts by

85 aging of the distal male reproductive tract (vas deferens, seminal vesicles, ejaculatory ducts).

86 m agonist exposure (0.5-4 hr) in the hamster vas deferens smooth muscle cell line (DDT1MF-2 cells).

87 s, present on many excitable cells including vas deferens smooth muscle cells.

88 P2X1 currents recorded from dissociated rat vas deferens smooth muscle cells.

89 Immunoelectron microscopy of vas deferens smooth muscle showed anti-RyR antibodies lo

90 The ryanodine receptor (RyR) in aortic and vas deferens smooth muscle was localized using immunoflu

91 the peripheral and central SR in aortic and vas deferens smooth muscle.

92 3.7% versus 33.2% +/- 10.3% (P < 0.0001) for vas deferens sperm and 40.1% +/- 9.6% versus 33.2% +/- 7

93 ion of the testis and associated structures (vas deferens, testicular vessels) and subsequent treatme

94 sensitization than those found in the native vas deferens tissue, in agreement with previous reports.

95 rkedly reduced contraction of the guinea pig vas deferens to electrical field stimulation (EFS) and n

96 -receptor-deficient mice, contraction of the vas deferens to sympathetic nerve stimulation is reduced

97 component of the contractile response of the vas deferens to sympathetic nerve stimulation, which pro

98 Phasic SMCs (vas deferens, uterus and bladder) rely on membrane depol

99 s (orchitis), epididymis (epididymitis), and vas deferens (vasitis).

100 MYPT1 in phasic rabbit portal vein (PV) and vas deferens (VD) smooth muscles.

101 D) (rat aorta), and alpha(2A) (rat prostatic vas deferens) was also evaluated.

102 The bigenic ampullary glands and vas deferens were extremely cystic, hypertrophic and hyp

103 e terminals and smooth muscle cells in mouse vas deferens were loaded with the Ca2+ indicator Oregon

104 ly-evoked contractions of the mouse isolated vas deferens when administered at submicromolar concentr

105 Superfusion of the vas deferens with exogenous epsilon-ATP, a fluorescent d

106 se in P2X1 protein expression in Entpd1(-/-) vas deferens with no variation in mRNA levels.